The structural integrity of vaccine antigens is critical to the generation of protective antibody responses, but the impact of protease activity on vaccination in vivo is poorly understood. We characterized protease activity in lymph nodes and found that antigens were rapidly degraded in the subcapsular sinus, paracortex, and interfollicular regions, whereas low protease activity and antigen degradation rates were detected in the vicinity of follicular dendritic cells (FDCs). Correlated with these findings, immunization regimens designed to target antigen to FDCs led to germinal centers dominantly targeting intact antigen, whereas traditional immunizations led to much weaker responses that equally targeted the intact immunogen and antigen breakdown products. Thus, spatially compartmentalized antigen proteolysis affects humoral immunity and can be exploited.
Molecular glue degraders (MGDs), such as pomalidomide, induce degradation of non-native substrates by the cullin-RING E3 ligase 4 (CRL4) through its substrate receptor cereblon (CRBN). Here, to explore CRBN programmability, we tested whether reported CRBN–MGD substrates are part of a network of latent CRBN interactors, proteins capable of MGD-induced CRBN binding without detectable degradation. Leveraging a highly parallel protein complementation assay (GluePCA) to measure MGD-induced interaction between CRBN and zinc fingers, we identified ~210 zinc fingers bound to CRBN–pomalidomide, where top binders are already reported as degraded by dedicated MGDs. To map latent CRBN–MGD interactions proteome-wide and define the accessible CRBN interaction space, we combined artificial intelligence-derived protein surface queries (MaSIF-mimicry) with GluePCA. This pipeline identified 6 known and 43 novel CRBN–pomalidomide binders, including orthogonally validated hits. We find that these binders provide privileged starting points for MGD development. We expect this binding-focused workflow to be applicable to other MGD–E3 ligase systems, potentially extending the scope of this emerging drug class.
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), members of the Pneumoviridae family, circulate widely and are leading causes of hospitalization for acute respiratory infections in infants and older adults. The viral fusion (F) protein in its prefusion (preF) conformation is the primary target of neutralizing antibodies, yet how naturally elicited circulating polyclonal antibodies are distributed across its antigenic landscape remains poorly understood. Here, we combined serological profiling, site-specific antibody competition assays and electron microscopy-based polyclonal epitope mapping (EMPEM) to characterize preF-directed immunity to RSV and hMPV in healthy adults. All donors exhibited detectable preF-binding antibodies that positively correlated with virus neutralization and broadly recognized multiple antigenic sites, consistent with immunodominance patterns predicted by a surface-centric computational model. Despite this overall similarity, the distribution of responses across individual antigenic sites differed between RSV and hMPV. EMPEM analyses revealed consistent targeting of the highly neutralization-sensitive preF apex (site Ø) in both viruses, alongside less abundant responses against equatorial and upper-middle epitopes (sites II, III, IV and V). We additionally observed antibody-bound destabilized preF, supporting a model in which antibody binding promotes transient opening of the preF trimer and may interfere with the conformational rearrangements required for membrane fusion. Together, these findings highlight apex-directed antibodies as a prominent feature of naturally acquired pneumovirus immunity in adults and reveal both shared and distinct patterns of antigenic recognition that may inform next-generation vaccine design and antibody-based prophylactics.